ArticleImmunology2018

ImmTAC/Anti-PD-1 antibody combination to enhance killing of cancer cells by reversing regulatory T-cell-mediated immunosuppression.

Huanling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.